Fanconi Anemia Research Fund: Research Grants

Funds interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi Anemia (FA). Proposals must address one or more of our research priorities:

• (Top Priority) To define the pathogenesis of Fanconi associated cancers, and to develop strategies for prevention, early detection, treatment, and cure.
• Novel Therapies: To develop ex vivo and in vivo gene therapy and gene editing technologies for FA.
• Bone Marrow Failure: To identify factors predictive of bone marrow failure, myelodysplastic syndrome, and leukemia, and associated treatment for high-risk populations.
• Manifestations of FA: To understand, prevent, and treat systemic, inflammatory, and aging manifestations of FA, including but not limited to: FA Neurological Syndrome (FANS), endocrine and fertility issues.
• Quality of Life: To identify practical and proactive management strategies that families and persons with FA can use to develop and maintain a high quality of life.
• Data Analytics: To use data analytics to identify biomarkers, hypotheses, risk predictions, and treatment for FA.
• Resource Sharing: To develop shared research resources and systems for allocation (i.e., tissue samples, cell lines, model systems, and data).

Funding: $25,000 – $250,000 over 1-2 years

www.fanconi.org/explore/apply-for-grant-funding